Genu Recurvatum Market Research Report- Global Forecast till 2023

Genu Recurvatum Market Research Report- Global Forecast till 2023

ID: MRFR/HC/3385-HCRR | | Region: Global | 85 pages | Half-Cooked Research Reports

Genu Recurvatum Market Research Report Information: Type (External, Internal, and Non-Rotatory Deformity), Diagnosis (MRI, X-Rays), Treatment (Physical Therapy, Orthoses, Bracing, Surgery), End User (Hospitals, Clinics, Labs) - Global Forecast till 2023 


Market Scenario


Genu Recurvatum is a rare orthopedic complication in which the hyperextension of the knee is greater than five degrees. It is also known as back knee or knee hyperextension. It occurs more frequently in females than it does in males, and is commonly, identified in 0.5%-1.0% of patients undergoing Total knee arthroplasty (TKA). This condition causes stress in the posterior knee structures which cause permanent damage of the joint. Genu recurvatum can also cause other conditions such as knee pain or knee osteoarthritis. Genu recurvatum can be mild, moderate, or severe. This deformity can also arise from other medical conditions such as, quadriceps weakness, bone deformities, paralysis, plantar foot flexion, and high tibial ostotomies. 


Genu recurvatum can be congenital or acquired. Congenital genu recurvatum (CGR) is an extremely rare condition, and found to be associated with other malformations such as talipes equinovarus, hip dysplasia, and absent patella. Signs and symptoms of this medical condition includes pain in the inner-leg portion of knee also known as medial tibiofemoral joint, pain in the outer back portion of knee also known as posterolateral ligamentous structures, extension of gait pattern, and difficulty in performing endurance activities. Genu recurvatum can be of three types, i.e. external rotatory deformity (ERD), internal rotatory deformity (IRD), and non-rotatory deformity (NRD). Out of three, ERD, and NRD are more severe, as ERD leads to soft tissue damage in which lower legs angle outward. Whereas, NRD, produces stress to the posterior soft tissue structures of knee. In some developing, and under developed regions, burden of orthopedics condition is rising due to lack of awareness. According to a study published in Indian Journal of Orthopaedics (IJO) in 2016, deficient orthopedic services and education such as, poor surgeon–patient ratio, poorly trained physicians to deal with musculoskeletal emergencies, and absence of minimum standard of orthopedic care, have been observed in some part of India. However, the Indian Orthopaedic Association (IOA) along with government health planners, individual medical practitioners, and medical educationists are working to find remedial solutions to these problems.


Notably, the market is expected to expand in the near future due to rise in geriatric population, high unmet needs of current treatment, and increase in research and development expenditure. Increase in aging population is the major market driver because the risk of orthopedic disorders increases exponentially with age. According to the data suggested by WHO in 2015, it is found that, worldwide, one in eight people was aged 60 years or over and by 2030, older people are projected to account for one in six people globally.


Despite these drivers, there are some issues associated with genu recurvatum market. High cost of treatment & management of genu recurvatum and related disorders, and lack of infrastructure in middle and low income countries may hamper the growth of the market.


It is estimated that genu recurvatum market is expected to grow at a CAGR 4.5% during the forecast period of 2017-2023.


Intended Audience



  • Hospitals

  • Surgical equipment Companies

  • Diagnostic clinics

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities 


Figure: Global Genu Recurvatum Market, By Region Market Share, 2017 (%)

Genu Recurvatum Market


Sources: Annual reports, Press release, White paper, Company presentation


 


Segmentation
The Genu recurvatum market is segmented on the basis of type, diagnosis, treatment, and end-user.


On the basis of type, market is segmented into external rotatory deformity (ERD), internal rotatory deformity (IRD), and non-rotatory deformity (NRD).


On the basis of diagnosis, market is segmented into magnetic resonance imaging (MRI), X-rays, and others.


On the basis of treatment, market is classified into physical therapy, orthoses, bracing, and surgery.


On the basis of end-user, market is segmented into hospital, clinics, and others.


 


Regional Analysis
The Americas dominate the Genu recurvatum market owing to the rising awareness among people, and increasing healthcare expenditure. The Centers for Disease Control and Prevention (CDC) has stated that out of total annual healthcare expenditure, 86% is for people with chronic health conditions in the United States. Furthermore, increasing participation of bigger players and new marketers towards advancement in treatment approaches have also attracted a great deal of attention.


Europe holds the second position in the Genu recurvatum market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region.


Asia Pacific is the fastest growing Genu recurvatum market owing to the huge patient pool and developing healthcare technology.


The Middle East & Africa has the lowest market for rabies treatment market due to lack of technical knowledge and poor medical facilities. 


Key Players
Some of key the players in the market are DePuy Synthes Companies (Part of Johnson & Johnson Services, Inc.), Globus Medical, Inc., Medtronic plc, NuVasive, Inc., Smith & Nephew plc, Stryker Corporation, Zimmer Inc and others.


Research Methodology



Genu Recurvatum Market-


Sources: Annual reports, Press release, White paper, and Company presentation




Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Genu Recurvatum Market, by Type

6.1 Introduction

6.2 External Rotatory Deformity (ERD)

6.2.1 Market Estimates & Forecast, 2017 – 2023

6.3 Internal Rotatory Deformity (IRD)

6.3.1 Market Estimates & Forecast, 2017 – 2023

6.4 Non-Rotatory Deformity (NRD)

6.4.1 Market Estimates & Forecast, 2017 – 2023



Chapter 7. Global Genu Recurvatum Market, by Diagnosis

7.1 Introduction

7.2 Magnetic Resonance Imaging (MRI)

7.2.1 Market Estimates & Forecast, 2017 – 2023

7.3 X-rays

7.3.1 Market Estimates & Forecast, 2017 – 2023

Chapter 8. Global Genu Recurvatum Market, by treatment

8.1 Introduction

8.2 Physical Therapy

8.2.1 Market Estimates & Forecast, 2018 – 2023

8.3 Orthoses

8.3.1 Market Estimates & Forecast, 2018 – 2023

8.4 Bracing

8.4.1 Market Estimates & Forecast, 2018 – 2023

8.5 Surgery

8.5.1 Market Estimates & Forecast, 2018 – 2023



Chapter 9. Global Genu Recurvatum Market, by End User

9.1 Introduction

9.2 Hospitals

9.2.1 Market Estimates & Forecast, 2017 – 2023

9.3 Clinics

9.2.2 Market Estimates & Forecast, 2017 – 2023

9.3 Others

Chapter 10. Global Genu Recurvatum Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe



10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 DePuy Synthes Companies

12.1.1 Company Overview

12.1.2 Types Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Globus Medical, Inc.

12.2.1 Company Overview

12.2.2 Types Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Medtronic plc

12.3.1 Company Overview

12.3.2 Types Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 NuVasive, Inc.

12.4.1 Company Overview

12.4.2 Types/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis



12.5 Smith & Nephew plc

12.5.1 Company Overview

12.5.2 Types Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Stryker Corporation

12.6.1 Company Overview

12.6.2 Types Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Zimmer Inc

12.7.1 Overview

12.7.2 Types Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Genu Recurvatum industry

Chapter 14 Appendix

LIST OF TABLES

Table 1 Genu Recurvatum Industry Synopsis, 2017 – 2023

Table 2 Genu Recurvatum Market Estimates and Forecast, 2017 – 2023, (USD Million)

Table 3 Genu Recurvatum Market by Region, 2017 – 2023, (USD Million)

Table 4 Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 5 Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 6 Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 7 Genu Recurvatum Market by End Users, 2017 – 2023, (USD Million)

Table 8 North America Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 9 North America Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 10 North America Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 11 North America Genu Recurvatum Market by End Users, 2017 – 2023, (USD Million)

Table 12 US Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 13 US Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 14 US Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 15 US Genu Recurvatum Market by End Users, 2017 – 2023, (USD Million)

Table 16 Canada Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 17 Canada Genu Recurvatum market by Diagnosis, 2017 – 2023, (USD Million)

Table 18 Canada Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 19 Canada Genu Recurvatum market by End Users, 2017 – 2023, (USD Million)

Table 20 South America Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 21 South America Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 22 South America Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 23 South America Genu Recurvatum Market by End Users, 2017 – 2023, (USD Million)

Table 24 Europe Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 25 Europe Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 26 Europe Genu Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 27 Europe Genu Recurvatum Market by End Users, 2017 – 2023, (USD Million)

Table 28 Western Europe Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 29 Western Europe Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 30 Western Europe Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 31 Western Europe Genu Recurvatum Market by End Users, 2017 – 2023, (USD Million)

Table 32 Eastern Europe Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 33 Eastern Europe Genu Recurvatum market by Diagnosis, 2017 – 2023, (USD Million)

Table 34 Eastern Europe Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 35 Eastern Europe Genu Recurvatum Market by End Users, 2017 – 2023, (USD Million)

Table 36 Asia Pacific Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 37 Asia Pacific Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 38 Asia Pacific Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 39 Asia Pacific Genu Recurvatum market by End Users, 2017 – 2023, (USD Million)

Table 40 Middle East & Africa Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 41 Middle East & Africa Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 42 Middle East & Africa Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 43 Middle East & Africa Genu Recurvatum market by End Users, 2017 – 2023, (USD Million)



LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Genu Recurvatum Market

Figure 3 Segmentation Market Dynamics for Genu Recurvatum Market

Figure 4 Global Genu Recurvatum market Share, by Types 2016

Figure 5 Global Genu Recurvatum market Share, by Diagnosis 2016

Figure 5 Global Genu Recurvatum market Share, by Treatment 2016

Figure 6 Global Genu Recurvatum market Share, by End Users, 2016

Figure 7 Global Genu Recurvatum market Share, by Region, 2016

Figure 8 North America Genu Recurvatum market Share, by Country, 2016

Figure 9 Europe Genu Recurvatum market Share, by Country, 2016

Figure 10 Asia Pacific Genu Recurvatum market Share, by Country, 2016

Figure 11 Middle East & Africa Genu Recurvatum market Share, by Country, 2016

Figure 12 Global Genu Recurvatum market: Company Share Analysis, 2016 (%)

Figure 13 DePuy Synthes: Key Financials

Figure 14 DePuy Synthes: Segmental Revenue

Figure 15 DePuy Synthes: Geographical Revenue

Figure 16 Globus Medical, Inc: Key Financials

Figure 17 Globus Medical, Inc.: Segmental Revenue

Figure 18 Globus Medical, Inc.: Geographical Revenue

Figure 19 Medtronic plc: Key Financials

Figure 20 Medtronic plc: Segmental Revenue

Figure 21 Medtronic plc: Geographical Revenue

Figure 22 NuVasive, Inc.: Key Financials

Figure 23 NuVasive, Inc.: Segmental Revenue

Figure 24 NuVasive, Inc.: Geographical Revenue

Figure 25 Smith & Nephew plc: Key Financials

Figure 26 Smith & Nephew plc: Segmental Revenue

Figure 27 Smith & Nephew plc: Geographical Revenue

Figure 28 Stryker Corporation: Key Financials

Figure 29 Stryker Corporation: Segmental Revenue

Figure 30 Stryker Corporation: Geographical Revenue

Figure 31 Zimmer Inc: Key Financials

Figure 32 Zimmer Inc: Segmental Revenue

Figure 33 Zimmer Inc: Geographical Revenue